NDC 57894-640 – Tremfya
Guselkumab 100 mg/mL · Injection · Subcutaneous
Product NDC57894-640
Product details
- Brand name
- Tremfya
- Generic name
- Guselkumab
- Labeler
- Janssen Biotech, Inc.
- Dosage form
- Injection
- Route
- Subcutaneous
- Marketing category
- BLA · BLA761061
- Marketed since
- July 13, 2017
- Listing expires
- December 31, 2027
- Pharmacologic class
- Interleukin-23 Antagonist
Active ingredients
- Guselkumab 100 mg/mL
Package NDC codes (5)
| Package NDC | Description | Since |
|---|---|---|
| 57894-640-01 | 1 SYRINGE in 1 CARTON (57894-640-01) / 1 mL in 1 SYRINGE | Jul 13, 2017 |
| 57894-640-04 | 1 SYRINGE in 1 CARTON (57894-640-04) / 1 mL in 1 SYRINGE | Jul 13, 2017 |
| 57894-640-06 | 1 SYRINGE in 1 CARTON (57894-640-06) / 1 mL in 1 SYRINGE (57894-640-03) | Mar 25, 2025 |
| 57894-640-11 | 1 SYRINGE in 1 CARTON (57894-640-11) / 1 mL in 1 SYRINGE | Jan 28, 2019 |
| 57894-640-99 | 1 SYRINGE in 1 CARTON (57894-640-99) / 1 mL in 1 SYRINGE | Jan 28, 2019 |
Recalls mentioning this NDC
- D-0314-2021 Apr 7, 2021 · Class III
Temperature Abuse